SPL 0.00% 9.7¢ starpharma holdings limited

PH3 Trials timeline, page-8

  1. 2,279 Posts.
    lightbulb Created with Sketch. 333
    Just look at the SP in the lead up to the 2012 Trial for BV. So much anticipation. It failed and subsequently the SP crashed.

    NOW

    That failed trial looks to be a success due to some rule changes by the FDA and the new trials for prevention of recurrence are about to finish. As you said there is no anticipation in the market at all! Either we are stupid and the market knows something we do not OR we all should be buying up a storm while we still can!!!
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.